Refine by
980 results found
-
NAMI in the News: Year in Review
In 2015, NAMI helped shape the national conversation on mental health across the country. Here is a look back at some of the articles where NAMI played a part. -
$400 Million Boost In Budget for Mental Health
The House and Senate passed and the President signed the $1.1 trillion 2016 budget bill (HR 2029) late last Friday, Dec. 18. Learn more about what this exctiting new bill includes about mental health research and services. -
A Holiday Gift From the Senate
Late last week, the U.S. Senate passed a bill (S.993) reauthorizing and expanding the Mentally Ill Offender and Treatment Crime Reduction Act (MIOTCRA). -
Learning to Survive When It’s Your Job to Witness Tragedies
Former highway patrol officer, Andy O' Hara, opens up about PTSD and his efforts to prevent law enforcement suicide. -
How You Can Get the Right Mental Health Treatment
We created some tips and reminders to guide you through the process of finding the help you need. -
Time to RAISE the Amount of Care
Discover the Recovery After Initial Schizophrenia Episode (RAISE) program that helps people who live with schizophrenia. -
4 Pillars of Mental Health Supported by 4 Strong Programs
The winners of the Conenct 4 Mental Health Innovation Awards have been announced! Here are the winning programs for the each of the pillars: early intervention, creative use of technology, continuity of care and service integration. -
NAMI Affiliates Play A Key Role In The Success Of CIT
As NAMI members have followed in the footsteps of NAMI Memphis to help start hundreds of CIT programs in communities nationwide, they have learned a lot about what makes a successful CIT program, and the role NAMI Affiliates can play. -
Saving Lives, Changing Communities
Following the shooting of a man living with mental illness in 1988, NAMI Memphis leaders' efforts with the Memphis police led to the nation’s first crisis intervention team (CIT). -
Changes Announced for Monitoring Clozapine to Improve Delivery of Treatment, Increase Access
The FDA has announced changes to how the side effects of the drug, Clozapine, the only FDA-approved medicine for treatment resistant schizophrenia, will be monitored.